全文获取类型
收费全文 | 5491篇 |
免费 | 288篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 83篇 |
妇产科学 | 75篇 |
基础医学 | 629篇 |
口腔科学 | 118篇 |
临床医学 | 351篇 |
内科学 | 1652篇 |
皮肤病学 | 173篇 |
神经病学 | 420篇 |
特种医学 | 221篇 |
外科学 | 841篇 |
综合类 | 39篇 |
预防医学 | 122篇 |
眼科学 | 67篇 |
药学 | 356篇 |
中国医学 | 33篇 |
肿瘤学 | 583篇 |
出版年
2023年 | 34篇 |
2022年 | 68篇 |
2021年 | 132篇 |
2020年 | 92篇 |
2019年 | 92篇 |
2018年 | 138篇 |
2017年 | 111篇 |
2016年 | 138篇 |
2015年 | 144篇 |
2014年 | 164篇 |
2013年 | 192篇 |
2012年 | 367篇 |
2011年 | 403篇 |
2010年 | 214篇 |
2009年 | 205篇 |
2008年 | 331篇 |
2007年 | 367篇 |
2006年 | 331篇 |
2005年 | 325篇 |
2004年 | 330篇 |
2003年 | 375篇 |
2002年 | 329篇 |
2001年 | 70篇 |
2000年 | 45篇 |
1999年 | 83篇 |
1998年 | 76篇 |
1997年 | 45篇 |
1996年 | 63篇 |
1995年 | 45篇 |
1994年 | 73篇 |
1993年 | 40篇 |
1992年 | 53篇 |
1991年 | 31篇 |
1990年 | 30篇 |
1989年 | 29篇 |
1988年 | 25篇 |
1987年 | 38篇 |
1986年 | 15篇 |
1985年 | 16篇 |
1984年 | 14篇 |
1982年 | 21篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 14篇 |
1976年 | 5篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1970年 | 5篇 |
排序方式: 共有5818条查询结果,搜索用时 15 毫秒
71.
Inhibition of autophagy by chloroquine makes chemotherapy in nasopharyngeal carcinoma more efficient
Tomomi Aga Kazuhira Endo Akira Tsuji Mitsuharu Aga Makiko Moriyama-Kita Takayoshi Ueno Yosuke Nakanishi Miyako Hatano Satoru Kondo Hisashi Sugimoto Naohiro Wakisaka Tomokazu Yoshizaki 《Auris, nasus, larynx》2019,46(3):443-450
Objectives
A combination of platinum-based chemotherapy and radiotherapy is the standard treatment for nasopharyngeal carcinoma (NPC). However, the efficacy of chemotherapy has reached a plateau. Many autophagy studies suggest that autophagy can either promote or suppress to cancer progression. Thus, a role of autophagy in the acquisition of chemoradioresistance has recently been a notable event. Therefore, we examined the relationship between autophagy and chemotherapy in NPC.Methods
The expression of Beclin 1 and microtubule-associated protein light chain 3 (LC3), a marker of autophagy, was determined by immunohistochemistry in the biopsy samples of patients with NPC before and after the first course of chemotherapy. Additionally, to investigate in the effect of autophagy suppression in chemotherapy, NPC cell line C666-1 cells were treated with cisplatin and/or chloroquine, an inhibitor of autophagy.Results
The expression of Beclin 1 increased after chemotherapy in all patients. In NPC cell line C666-1, compared to cisplatin alone, combination therapy (cisplatin and chloroquine) reduced cell viability, and promoted cell apoptosis.Conclusions
These results suggest that autophagy, represented by Beclin 1, is upregulated after chemotherapy in both in vitro and in vivo NPC studies. Inhibition of autophagy could therefore be new strategy for NPC treatment. 相似文献72.
Ryo Terayama Takahiro Ishikawa Kazuki Ishiwata Ai Sato Takuya Minamizuka Tomohiro Ohno Satomi Kono Masashi Yamamoto Hidetaka Yokoh Hidekazu Nagano Masaya Koshizaka Sawako Suzuki Hisashi Koide Yoshiro Maezawa Koutaro Yokote 《Internal medicine (Tokyo, Japan)》2022,61(22):3391
Cushing''s disease causes numerous metabolic disorders, cognitive decline, and sarcopenia, leading to deterioration of the general health in older individuals. Cushing''s disease can be treated with transsphenoidal surgery, but thus far, surgery has often been avoided in older patients. We herein report an older woman with Cushing''s disease whose cognitive impairment and sarcopenia improved after transsphenoidal surgery. Although cognitive impairment and sarcopenia in most older patients show resistance to treatment, our case indicates that normalization of the cortisol level by transsphenoidal surgery can be effective in improving the cognitive impairment and muscle mass loss caused by Cushing''s disease. 相似文献
73.
74.
Hiroyuki Inoue Atsushi Shiozaki Hitoshi Fujiwara Hirotaka Konishi Jun Kiuchi Takuma Ohashi Hiroki Shimizu Tomohiro Arita Yusuke Yamamoto Ryo Morimura Yoshiaki Kuriu Hisashi Ikoma Takeshi Kubota Kazuma Okamoto Eigo Otsuji 《Oncology Letters》2022,24(2)
Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal cancer. A total of 41 patients who received nivolumab treatment for recurrent esophageal cancer after esophagectomy were analyzed. The absolute lymphocyte count (ALC), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR) and C-reactive protein-albumin ratio (CAR) were assessed at the time of nivolumab induction as indices that can be calculated by blood biochemical examinations alone. Median values were 1,015 for ALC, 3.401 for NLR, 242.6 for PLR, 0.458 for MLR and 0.119 for CAR, and patients were divided into two groups according to values. A high ALC, low NLR, low PLR, low MLR and low CAR were associated with a better response to nivolumab. In addition, patients with the aforementioned indices, with the exception of low PLR, or better response were more likely to develop AEs in univariate analysis. In multivariate analysis, a high ALC [odds ratio (OR): 4.857, P=0.043] and low CAR (OR: 9.099, P=0.004) were identified as independent risk factors for AEs. Survival analysis revealed that overall survival and progression-free survival (PFS) rates after nivolumab treatment differed significantly between the high and low groups of ALC, NLR, PLR, MLR and CAR. The multivariate analysis identified a low ALC [hazard ratio (HR): 3.710, P=0.003] and high CAR (HR: 2.953, P=0.007) as independent poor prognostic factors of PFS. In conclusion, ALC and CAR have potential as biomarkers for outcomes of recurrent esophageal cancer following nivolumab treatment. 相似文献
75.
Hirotomo Dochi Satoru Kondo Takayuki Murata Masaki Fukuyo Asuka Nanbo Kousho Wakae WenPing Jiang Toshihide HamabeHoriike Mariko Tanaka Takumi Nishiuchi Harue Mizokami Makiko MoriyamaKita Eiji Kobayashi Nobuyuki Hirai Takeshi Komori Takayoshi Ueno Yosuke Nakanishi Miyako Hatano Kazuhira Endo Hisashi Sugimoto Naohiro Wakisaka ShinHun Juang Masamichi Muramatsu Atsushi Kaneda Tomokazu Yoshizaki 《Cancer science》2022,113(8):2862
76.
Kensei Yamaguchi Keiko Minashi Daisuke Sakai Tomohiro Nishina Yasushi Omuro Masahiro Tsuda Shiroh Iwagami Hisato Kawakami Taito Esaki Naotoshi Sugimoto Takashi Oshima Ken Kato Kenji Amagai Hisashi Hosaka Keigo Komine Hisateru Yasui Yuji Negoro Kenji Ishido Takahiro Tsushima Shirong Han Shinichi Shiratori Tomoko Takami Kohei Shitara 《Cancer science》2022,113(8):2814
The KEYNOTE‐659 study evaluated the efficacy and safety of first‐line pembrolizumab plus S‐1 and oxaliplatin (SOX) (cohort 1) or S‐1 and cisplatin (SP) (cohort 2) for advanced gastric/gastroesophageal junction (G/GEJ) cancer in Japan. Herein, we update the results of cohort 1 and describe the results of cohort 2. This open‐label phase IIb study enrolled patients with advanced programmed death‐ligand 1 (PD‐L1)‐positive (combined positive score ≥ 1) human epidermal growth factor receptor 2 (HER2)‐negative G/GEJ adenocarcinoma. The primary end‐point was the objective response rate (ORR). Other end‐points were duration of response (DOR), disease control rate (DCR), progression‐free survival (PFS), overall survival (OS), and safety. One hundred patients were enrolled. In cohorts 1 and 2, median follow‐up time was 16.9 and 17.1 months; ORR (central review), 72.2% and 80.4%; DOR, 10.6 and 9.5 months; DCR (central review), 96.3% and 97.8%; median PFS (central review), 9.4 and 8.3 months; and median OS, 16.9 and 17.1 months, respectively. Treatment‐related adverse events (TRAEs) occurred in all patients, including peripheral sensory neuropathy (94.4%, cohort 1), decreased neutrophil count (82.6%, cohort 2), nausea (59.3% and 60.9% in cohorts 1 and 2), and decreased appetite (61.1% and 60.9% in cohorts 1 and 2). Grade 3 or higher TRAEs were reported by 59.3% (cohort 1) and 78.3% (cohort 2), including decreased platelet count (14.8%, cohort 1) and decreased neutrophil count (52.2%, cohort 2). Pembrolizumab in combination with SOX or SP showed favorable efficacy and safety in patients with PD‐L1‐positive, HER2‐negative G/GEJ adenocarcinoma. 相似文献
77.
Jingjing Du Peiwen Zhang Jiang Luo Linyuan Shen Shunhua Zhang Hao Gu Jin He Linghui Wang Xue Zhao Mailing Gan Liu Yang Lili Niu Ye Zhao Qianzi Tang Guoqing Tang Dongmei Jiang Yanzhi Jiang Mingzhou Li Anan Jiang Long Jin Jideng Ma Surong Shuai Lin Bai Jinyong Wang Bo Zeng De Wu Xuewei Li Li Zhu 《Gut microbes》2021,13(1)
78.
79.
Ryota Sakurai Hisashi Kawai Hiroyuki Suzuki Hunkyung Kim Yutaka Watanabe Hirohiko Hirano Kazushige Ihara Shuichi Obuchi Yoshinori Fujiwara 《Journal of epidemiology / Japan Epidemiological Association》2021,31(4):297
ObjectivesEating alone is associated with an increased risk of depression symptoms. This association may be confounded by poor social networks. The present study aimed to determine the role of poor social networks in the association of eating alone with depression symptoms, focusing on cohabitation status.MethodsSeven hundred and ten community-dwelling older adults were categorized according to their eating style and social network size, evaluated using an abbreviated version of the Lubben Social Network Scale, with poor social network size (defined as the lowest quartile). Living arrangements and depression symptoms, detected using the Zung Self-Rating Depression Scale, were also assessed.ResultsA mixed-design two-way analysis of covariance (eating style and social network size factors) for the depression scale score, adjusted by covariates, yielded significant effects of social network size and eating style without interaction. Greater depression scores were observed in eating alone and poor social network size. Analysis of participants living with others showed the same results. However, among older adults living alone, only a significant main effect of social network size was observed; poor social network size resulted in greater depression scores irrespective of eating style.ConclusionsPoor social network size, and not eating alone, was associated with greater depression symptoms among older adults living alone, whereas both factors may increase depression symptoms among older adults living with others. Poor social network size may show a stronger influence on depression than eating alone in older adults living alone; thus, social network size is an important health indicator.Key words: eating alone, social network, living alone, depression, older adults 相似文献
80.
Kosuke Nomura Toshiro Iizuka Daisuke Kaji Hisashi Yamamoto Yasutaka Kuribayashi Ryusuke Kimura Akihiro Yamada Tsukasa Furuhata Satoshi Yamashita Daisuke Kikuchi Akira Matsui Toshifumi Mitani Osamu Ogawa Shu Hoteya Yasunori Ota Shuichi Taniguchi Mitsuru Kaise 《Journal of gastroenterology and hepatology》2014,29(11):1867-1872